Marta Barrachina
Barcelona, CT 08980, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer's disease dementia prognosis.
Journal: iScience
Published: April 09, 2025
Genetic and epigenetic changes to the glucocorticoid receptor gene (NR3C1) and cognition in major depressive disorder.
Journal: Spanish journal of psychiatry and mental health
Published: June 02, 2024
BDNF genetic variants and methylation: effects on cognition in major depressive disorder.
Journal: Translational psychiatry
Published: February 17, 2019
FKBP5 polymorphisms and hypothalamic-pituitary-adrenal axis negative feedback in major depression and obsessive-compulsive disorder.
Journal: Journal of psychiatric research
Published: May 06, 2018
Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease.
Journal: The American journal of pathology
Published: May 18, 2015
Striatal adenosine A2A receptor expression is controlled by S-adenosyl-L-methionine-mediated methylation.
Journal: Purinergic signalling
Published: April 11, 2014
Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b.
Journal: Neurobiology of disease
Published: February 10, 2014
Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.
Journal: Journal of psychiatric research
Published: September 02, 2013
Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis".
Journal: Purinergic signalling
Published: May 08, 2013
Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.
Journal: Neuromolecular medicine
Published: October 15, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026